Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04870268 |
Other study ID # |
example-1 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 2012 |
Est. completion date |
January 1, 2021 |
Study information
Verified date |
April 2021 |
Source |
University of Pisa |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
Several interventional and surgical procedures are available to treat moderate-to-critical
acute pancreatitis (AP) in its late phase. The ongoing debate on these options, together with
the scarcity of reported mid-term follow-up information in the Literature, prompted the
investigators to conduct a review of our surgical experience, focused on those issues. The
investigators reviewed retrospectively all the patients treated for moderate-to-critical AP
according to Determinant-Based Classification (DBC), in the last nine years. Patients treated
conservatively or operated within 4 weeks of the onset of the pancreatitis were excluded. All
the included patients were managed following a "tailored" step-up approach, and divided into
four groups, according to the first interventional procedure performed: percutaneous drainage
(PD), endoscopic approach (END), internal derivation (INT), and necrosectomy (NE).
In-hospital and mid-term follow-up variables, including a quality-of-life assessment, were
analyzed and compared.
Description:
The following variables were evaluated: sex, age, severity of inflammation according to the
DBC classification, PA etiology, CT scan severity index according to Balthazar criteria ,
clinical prognostic score using bedside index of severity of acute pancreatitis (BISAP)
score.
Total length of hospitalization, operative management, necrosis cultures, total and
post-interventional Intensive Unit Care (ICU) were also recorded and analyzed together with
the in-hospital morbidity, mortality and re-admissions.
Patients were checked after discharge within 14 days and followed monthly as outpatients by
gastroenterologists. A CT scan was performed within 4 months, or before in case of recurrent
symptoms. During the follow-up, the English Standard Short Form 36 (SF-36) questionnaire was
used to evaluate the general quality of life at three and six months, one and two years. The
SF-36 examines 8 areas consisting of social and physical function, physical and emotional
well-being, bodily pain, vitality, mental health and overall general health perception. At
the six-month follow-up, the patients also completed a specific questionnaire about the
pancreatic function. In particular, the total score takes in consideration abdominal pain
using visual analogue pain score, diarrhea, unintentional weight loss, new onset of diabetes
and use of enzyme supplementation. The score ranges between zero to five (all symptoms
present). The work has been reported in line with the STROCSS criteria